NOX1 and cystitis: We therefore designed the present study to evaluate whether NOX1/4 or NOX2 inhibition (by using GKT137831 or GSK2795039, respectively) improves ROS-generation, bladder hyperactivity, and inflammatory and nociceptive responses related to CYP-induced cystitis in mice.